Regulatory Auditor for the NYSE

The firm was approved by the SEC to serve as the Regulatory Auditor for the NYSE from 2005 to 2013, following the SEC’s findings in a Consent Order that the NYSE had failed to police specialists who were “interpositioning” and “trading ahead” of customer orders. The firm’s engagement covered ongoing audits of regulatory policies and procedures, including interviews with regulatory personnel, review of business requirements and functional specifications for automated surveillance technology, IT testing of regulatory controls, and observation of trading activity on the NYSE floor. The firm provided comprehensive, bi-annual reports to the SEC and NYSE, as well as frequent, interim reports to the NYSE as it completed individual audit procedures.

The New York Stock Exchange (NYSE) is one of the world’s largest and most liquid equities stock exchange.

You Also May Be Interested In:

  • We represented Pharos Capital’s post-acute care provider platform, Charter Health Care Group, in its acquisition of two hospice service providers,...
    Client Type: Private Company
  • Representation of axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15 million Series C round of financing to accelerate its expansion into the substance use disorder (SUD) treatment, and recovery sector. Previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund led the round.

    We represented axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15...
    Client Type: Private Company
  • Representation of Health Velocity Capital as lead investor in a $30 million Series C funding round for HealthJoy, a healthcare consumer benefits platform. In addition to Health Velocity Capital, other participating investors included U.S. Venture Partners, Chicago Ventures, and Epic Ventures

    We advised Health Velocity Capital as lead investor in a $30 million Series C funding round for HealthJoy, a healthcare...
    Client Type: Private Company